|1.||Koch, Walter J: 8 articles (04/2015 - 08/2003)|
|2.||Wallukat, Gerd: 8 articles (05/2014 - 01/2005)|
|3.||Schimke, Ingolf: 6 articles (05/2014 - 02/2010)|
|4.||Goetzl, Edward J: 6 articles (01/2011 - 02/2002)|
|5.||Sklar, Larry A: 5 articles (09/2013 - 06/2005)|
|6.||Edwards, Bruce S: 5 articles (09/2013 - 06/2005)|
|7.||Young, Susan M: 5 articles (09/2013 - 06/2005)|
|8.||Hollenberg, Morley D: 5 articles (01/2013 - 02/2003)|
|9.||Haberland, Annekathrin: 5 articles (01/2013 - 02/2010)|
|10.||Prossnitz, Eric R: 5 articles (09/2009 - 06/2005)|
05/01/2015 - "Free fatty acid receptors (FFAR) belong to a family of five G-protein coupled receptors that are involved in the regulation of lipid metabolism, so that their loss of function increases the risk of obesity. "
07/01/2009 - "The cooperation of ObRb and G protein-coupled receptors in cellular signaling may have considerable biological implications not restricted to feeding and obesity."
01/01/2009 - "Many orphan G-protein-coupled receptors (GPCR) have emerged as potential obesity targets. "
10/01/2004 - "Central G-Protein Coupled Receptors (GPCR)s as molecular targets for the treatment of obesity: assets, liabilities and development status."
10/01/2004 - "In addition to targeting known G protein-coupled receptors (GPCRs), several orphan GPCRs expressed in central nervous system areas known to regulate feeding may provide new targets for the treatment of obesity. "
|2.||Schizophrenia (Dementia Praecox)
07/22/2013 - "We focus on the bioaminergic receptors that belong to the group of G-protein-coupled receptors (GPCRs) and represent targets for therapeutic agents against schizophrenia and depression. "
04/01/2007 - "Although the molecular mechanisms underlying psychiatric illnesses such as depression, bipolar disorder and schizophrenia remain incompletely understood, there is increasing clinical, pharmacologic, and genetic evidence that G protein-coupled receptors (GPCRs) play critical roles in these disorders and their treatments. "
04/01/2009 - "The authors examined the efficacy of secretin, a hormonal agonist for the prototype group B G-protein-coupled receptors, in ameliorating eye-blink conditioning deficits in schizophrenia patients. "
09/15/2006 - "Linkage, association and postmortem studies have implicated regulator of G-protein signaling 4 (RGS4), which negatively modulates signal transduction at G-protein-coupled receptors, as a candidate schizophrenia susceptibility gene. "
10/01/2014 - "Current pharmacological treatments for schizophrenia target G protein-coupled receptors (GPCRs), including dopamine receptors. "
07/01/2012 - "These results suggest that interplay between presynaptic G protein-coupled receptors with overlapping downstream targets may underlie the variable efficacy of cannabinoids in different models of epilepsy."
06/01/2014 - "G protein-coupled receptors strongly modulate neuronal excitability but there has been little evidence for G protein mechanisms in genetic epilepsies. "
01/01/2007 - "Recent progress in ion channel research brought about by molecular cloning of the channel subunit proteins and studies in epilepsy models suggest additional targets, including G-protein-coupled receptors, such as GABA(B) and metabotropic glutamate receptors; hyperpolarization-activated cyclic nucleotide-gated cation (HCN) channel subunits, responsible for hyperpolarization-activated current Ih; connexins, which make up gap junctions; and neurotransmitter transporters, particularly plasma membrane and vesicular transporters for GABA and glutamate. "
11/18/2015 - "G Protein-Coupled Receptors: Dynamic Machines for Signaling Pain and Itch."
09/01/2015 - "Activation of Mas Oncogene-Related G Protein-Coupled Receptors Inhibits Neurochemical Alterations in the Spinal Dorsal Horn and Dorsal Root Ganglia Associated with Inflammatory Pain in Rats."
08/01/2015 - "Drugs that target G protein-coupled receptors (GPCRs) represent the primary treatment strategy for patients with acute and chronic pain; however, there is substantial individual variability in both the efficacy and adverse effects associated with these drugs. "
08/01/2015 - "Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management."
01/01/2015 - "PKs bind two G protein coupled receptors, PKR1 and PKR2, and participate in the regulation of several biological processes, including pain sensation. "
|5.||Alzheimer Disease (Alzheimer's Disease)
08/03/2011 - "We found that, together with an increase in the passive Ca(2+) influx, a significant reduction in the sensitivity of G protein-coupled receptors might lie beneath the abnormalities in the astrocytic Ca(2+) signaling, as was observed in rodent models of Alzheimer's disease. "
02/01/2011 - "The role of G protein-coupled receptors in the pathology of Alzheimer's disease."
01/01/2009 - "G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease."
03/30/2007 - "Alterations in signal transduction pathway of G-protein-coupled receptors (GPCRs) have been found in the cerebrocortex and in the peripheral cultured tissues of patients with Alzheimer's disease (AD). "
05/01/2014 - "Emerging evidence indicates that β-arrestin 2, an important regulator of G protein coupled receptors, is involved in the pathogenesis of Alzheimer's disease (AD). "
|1.||Serotonin (5 Hydroxytryptamine)
|2.||Transcription Factors (Transcription Factor)
|3.||Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
|5.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
|7.||metabotropic glutamate receptor 5
|8.||GTP-Binding Proteins (G-Protein)
|9.||Proteins (Proteins, Gene)
|10.||Epidermal Growth Factor (EGF)
|2.||Drug Therapy (Chemotherapy)
|4.||Heterologous Transplantation (Xenotransplantation)